📰 Rx Solutions News
Rx Solutions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rx Solutions. Real-time updates on events, politics, business and more.
May 6, 2024
/PRNewswire/ -- The global industrial computed tomography equipment market size is estimated to grow by USD 131.34 million from 2023 to 2027, according to...
December 16, 2022
/PRNewswire/ -- According to Technavio, the global industrial computed tomography equipment market size is estimated to grow by USD 131.34 million from 2023 to...
December 16, 2022
/PRNewswire/ -- According to Technavio, the global industrial computed tomography equipment market size is estimated to grow by USD 131.34 million from 2023 to...
December 13, 2022
Global Industrial Computed Tomography Equipment Market 2023-2027 The analyst has been monitoring the industrial computed tomography equipment market and it...
May 19, 2022
/PRNewswire/ -- The "Industrial Computed Tomography Systems, 2022" report has been added to ResearchAndMarkets.coms offering. This report reveals the market...
May 19, 2022
/PRNewswire/ -- The "Industrial Computed Tomography Systems, 2022" report has been added to ResearchAndMarkets.coms offering. This report reveals the market...
May 5, 2022
/PRNewswire/ -- tangoRx Solutions, a mission-centric company focused exclusively on serving organizations who provide care to vulnerable patient populations,...
May 5, 2022
McKesson Corporation (NYSE:NYSE:MCK) Q4 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Rachel Rodriguez - Vice President, Investor Relations Brian Tyler - Chief...
March 17, 2021
Abstract Breast cancer frequently metastasizes to bone, causing osteolytic lesions. However, how factors secreted by primary tumors affect the bone microenvironment before the osteolytic phase of metastatic tumor growth remains unclear. Understanding these changes is critical as they may regulate metastatic dissemination and progression. To mimic premetastatic bone adaptation, immunocompromised mice were injected with MDA-MB-231–conditioned medium [tumor-conditioned media (TCM)]. Subsequently...